ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals Inc (MRNS)

1.405
-0.07
( -4.75% )
Updated: 12:00:01

Marinus Pharmaceuticals Inc Financial Summary

The current MRNS market cap is 77.18M. The company's latest EPS is USD -2.5741 and P/E is -0.56.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 10.38M6.08M7.34M7.19M7.68M
Operating Income -32.96M-31.44M-31.65M-35.44M-35.82M
Net Income -34.73M-31.93M-32.97M-41.77M-38.67M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 01.72M15.35M25.48M30.99M
Operating Income -54.42M-67.94M-96.93M-112.79M-131.49M
Net Income -54.12M-67.48M-98.78M-19.82M-141.41M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 226.82M201.2M200.81M170.91M137.35M
Total Liabilities 141.73M143.86M146.27M154.14M153.78M
Total Equity 85.09M57.34M54.54M16.77M-16.43M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 98.84M150.46M136.84M259.52M170.91M
Total Liabilities 11.07M13.26M83.35M143.52M154.14M
Total Equity 59.57M137.2M53.49M116M16.77M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -41.48M-65.84M-91.01M-118M-37.46M
Investing -52M-46.99M-35.07M-28.61M20.89M
Financing -174k63k25.97M26.63M257k
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -48.63M-60.91M-55.48M-112.89M-118M
Investing 3.88M-738k-1.42M105.77M-28.61M
Financing 67.97M109.22M41.31M124.74M26.63M
Market Cap 77.18M
Price to Earnings Ratio -0.56
Price to Sales Ratio 2.54
Price to Cash Ratio 0.65
Price to Book Ratio 4.69
Dividend Yield -

Share Statistics

Shares Outstanding 54.93M
Average Volume (1 week) 807.43k
Average Volume (1 Month) 1.24M
52 Week Change -85.92%
52 Week High 11.26
52 Week Low 1.10
Spread (Intraday) 0.01 (0.71%)

Company Info

Company Name Marinus Pharmaceuticals Inc
Address 3411 silverside road tatnall building
wilmington, delaware 19810
Website https://www.marinuspharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock